FDA warns Hims & Hers that its semaglutide products are misbranded due to misleading claims and asks for corrective steps within 15 days.
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
Where Today's News Shapes Tomorrow
